Intuniv gains indication as adjunctive therapy in ADHD - ONA
Links shared publicly online about this topic.
- 473total visits
Intuniv gains indication as adjunctive therapy in ADHD - ONA
View full resource at oncologynurseadvisor.com
Tags: ADHD, ADHD Medication, Disease and Condition, FDA, Intuniv, Shire, Pediatric ADHD
Most Recently Shared on February 28, 2011 at 3:40 pm By:
Intuniv gains indication as adjunctive therapy in ADHD http://goo.gl/fb/srbUs
INTUNIV (Guanfacine) drug information from MPR
empr.com — “INTUNIV (Guanfacine) drug information for ADD, ADHD {ADHD} from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on April 13, 2011 at 4:19 am By:
MPR News: INTUNIV: Indications: approved as adjunctive therapy. Children: adjunctive therapy dosing added. http://bit.ly/dTFdne
Intuniv gains indication as adjunctive therapy in ADHD - MPR
empr.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.” View full resource at empr.com
Most Recently Shared on February 28, 2011 at 3:44 pm By:
MPR News: Intuniv gains indication as adjunctive therapy in ADHD: Shire announced that the FDA has approved Intu... http://bit.ly/eyR7Gr
Advertisement
